Structures by: Yan C. W.
Total: 18
5-fluorouracil L-phenylalanine
C4H3FN2O2,C9H11NO2
CrystEngComm (2020)
a=7.00870(10)Å b=12.3981(2)Å c=15.1304(3)Å
α=90° β=90° γ=90°
Sulfathiazole amantadine salt
C9H8N3O2S2,C10H18N
CrystEngComm (2020)
a=8.8101(4)Å b=17.1707(8)Å c=13.2499(7)Å
α=90° β=101.100(2)° γ=90°
C86H64Cl8F6N30Ni5PRu2S2
C86H64Cl8F6N30Ni5PRu2S2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 20 6635-6643
a=38.6072(15)Å b=14.9578(6)Å c=17.7771(8)Å
α=90° β=115.2998(12)° γ=90°
Tegafur Syringic acid
C4H4.5F0.5NO1.5,C4.5H5O2.5
New Journal of Chemistry (2020) 44, 37 15994-16005
a=9.2818(13)Å b=6.7034(10)Å c=14.154(2)Å
α=90° β=95.260(4)° γ=90°
Indomethacin L-proline
C24H27ClN2O7
New Journal of Chemistry (2020) 44, 10 3930-3939
a=12.4240(5)Å b=5.7358(2)Å c=16.3820(6)Å
α=90° β=101.436(4)° γ=90°
C20H28ClCu2N7O5S2
C20H28ClCu2N7O5S2
New Journal of Chemistry (2014) 38, 7 2964
a=12.929(6)Å b=13.466(6)Å c=15.957(7)Å
α=90° β=99.945(8)° γ=90°
C22H26ClCu2N5O10S2
C22H26ClCu2N5O10S2
New Journal of Chemistry (2012) 36, 12 2472
a=11.8016(15)Å b=11.8840(14)Å c=12.652(3)Å
α=103.236(3)° β=101.213(3)° γ=117.145(2)°
C40H44Cl2Cu4N14O18S4
C40H44Cl2Cu4N14O18S4
New Journal of Chemistry (2012) 36, 12 2472
a=13.9583(13)Å b=25.467(2)Å c=15.4276(15)Å
α=90.00° β=103.572(6)° γ=90.00°
C23H26ClCu2N5O10
C23H26ClCu2N5O10
New Journal of Chemistry (2012) 36, 10 2078
a=10.2352(2)Å b=11.7803(2)Å c=12.9715(2)Å
α=79.1190(10)° β=71.6090(10)° γ=64.3420(10)°
C23H26Cu2N6O7
C23H26Cu2N6O7
New Journal of Chemistry (2012) 36, 10 2078
a=9.876(4)Å b=11.210(4)Å c=11.834(5)Å
α=92.410(7)° β=110.147(7)° γ=95.229(7)°
C21H24Cu2N6O8
C21H24Cu2N6O8
New Journal of Chemistry (2012) 36, 10 2078
a=23.6799(4)Å b=9.7018(2)Å c=10.27770(10)Å
α=90.00° β=90.00° γ=90.00°
C9H15N5O5S2
C9H15N5O5S2
CrystEngComm (2019) 21, 19 3064
a=5.2350(4)Å b=10.4510(9)Å c=13.2627(11)Å
α=80.451(3)° β=85.302(3)° γ=83.095(3)°
C25H33ClCu2N6O10
C25H33ClCu2N6O10
RSC Adv. (2015) 5, 64 51730
a=7.9614(8)Å b=23.877(2)Å c=8.4244(8)Å
α=90.00° β=109.146(3)° γ=90.00°
C22H29Cl2Cu2N5O7
C22H29Cl2Cu2N5O7
RSC Adv. (2015) 5, 64 51730
a=10.9647(8)Å b=11.4494(9)Å c=11.6578(9)Å
α=85.9120(10)° β=74.6800(10)° γ=71.0260(10)°
(Aqua-2κ<i>O</i>)bis(2,2-bipyridine-1κ^2^<i>N</i>,<i>N</i>'){μ-<i>N</i>- [3-(dimethylamino)propyl]-<i>N</i>'-(2-oxidophenyl)oxamidato(3-)- 1:2κ^2^<i>O</i>,<i>O</i>':κ^4^<i>O</i>'',<i>N</i>,<i>N</i>',<i>N</i>''} copper(II)nickel(II) perchlorate
C33H34CuN7NiO4,ClO4
Acta Crystallographica Section C (2011) 67, 4 m115-m118
a=11.4692(5)Å b=11.8976(5)Å c=15.1818(7)Å
α=92.261(3)° β=109.043(3)° γ=112.911(3)°
Tetrakis(2,2-bipyridine)-1κ^4^<i>N</i>,<i>N</i>';4κ^4^<i>N</i>,<i>N</i>'- {μ~4~-<i>N</i>,<i>N</i>'-bis[3-(2-oxidoethylamino)propyl]oxamidato(4-)- 1:2:3:4κ<i>O</i>:κ^3^<i>N</i>,<i>N</i>',<i>O</i>':κ^3^<i>O</i>'', <i>N</i>'',<i>N</i>''':κ<i>O</i>'''}tetracopper(II) tetrakis(perchlorate)
C52H54Cu4N12O44,4(ClO4)
Acta Crystallographica Section C (2010) 66, 8 m211-m214
a=14.617(3)Å b=33.273(7)Å c=13.897(3)Å
α=90.00° β=109.39(3)° γ=90.00°
<i>catena</i>-Poly[[(2,2-diamino-4,4'-bithiazole){μ~3~-<i>cis</i>-<i>N</i>- (2-carboxylatophenyl)-<i>N</i>'-[3- (dimethylamino)propyl]oxamidato(3-)}dicopper(II)] nitrate 0.6-hydrate]
C20H22Cu2N7O4S2,NO3,0.6(H2O)
Acta Crystallographica Section C (2010) 66, 11 m323-m326
a=12.6991(3)Å b=14.0263(3)Å c=15.0300(3)Å
α=90.00° β=107.103(2)° γ=90.00°
Diacetonitrile-1κN,3κN-bis{μ-trans-N-[3-(dimethylamino)propyl]-N- (2-hydroxyethyl)oxamidato(2-)}-1:2κ^5^N,N',O:O',N'';2:3κ^5^O',N'':N,N',O- dithiocyanato-1κN,3κN-tricopper(II)
C24H40Cu3N10O6S2
Acta Crystallographica Section C (2008) 64, 4 m149-m152
a=6.040(5)Å b=8.262(6)Å c=17.256(13)Å
α=91.999(10)° β=97.831(10)° γ=96.185(10)°